Voice of Pharma Study: Sponsor Views on Clinical Data Analytics and AI

Register Free: https://www.appliedclinicaltrialsonline.com/act/clinical-data-analytics

Event overview

With increasing pressures on clinical development from various factors including hybrid and decentralized trial implementation and the growth of external data sources, artificial intelligence (AI) and data analytics show promise to drive greater expediency and efficiency, as well as reduce costs in this area. How prepared are clinical development professionals to enable AI and analytics to better ingest, integrate, standardize, monitor, and predict from a range of applicable data sources to improve experiences of sponsors, researchers, and patients?

In this webinar, IQVIA, in partnership with Frost & Sullivan, will share recent qualitative and quantitative results from its “Voice of Pharma Study: Sponsor Views on Clinical Data Analytics and Artificial Intelligence” gleaned from pharma sponsors surveyed on their views.

Three key take-aways

Daniel Ruppar
Consulting Director, Healthcare & Life Sciences
Frost & Sullivan

Daniel has over 18 years in healthcare and life sciences in various consulting, management, and analyst roles, working with big tech, pharma, medical imaging, and digital health clients. He also spent 9 years in the pharma industry in drug research & development.

Gary Shorter
Head, AI and Data Science
IQVIA Technologies

Gary pursues the use of emerging technology to provide new and more efficient capabilities to enhance clinical trial management. This includes development of new design software through to more recent advancements with AI/ML capabilities where his team has developed several micro-products and micro-services that can be plugged in and used by any SaaS solution.

Wendy Morahan
Sr Director Product CDAS
IQVIA Technologies

Wendy has 25+ years experience in the life sciences industry with a career spanning academic research, preclinical drug discovery, and clinical trials, culminating in a focus and passion for delivering technology solutions that help bring treatments to patients faster. Wendy is currently part of the product strategy leadership team for IQVIA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs. As part of the CDAS team, Wendy is responsible for strategy, product management leadership, and Go to Market activities.

Dimitrios Mizantzidis
Director Product Marketing CDAS
IQVIA Technologies

Dimitrios leads marketing for the Clinical Data Analytics Suite (CDAS) for IQVIA Technologies. He is passionate about solving customer data analytics needs via easy to understand and implement SaaS solutions. Prior to joining IQVIA Technologies in November ‘22, Dimitrios led several marketing teams with other Healthcare IT companies such as GE Healthcare IT and 3M Health Information Systems etc.